Permanent Introduction of Premium for New Drug Development One of PhRMA’s “Priorities in 2013”: Japan Chair

February 5, 2013
Mr Zulueta (left), Dr Lechleiter Meet Press in Tokyo The Pharmaceutical Research and Manufacturers of America (PhRMA) will push for the permanent introduction of the premium for new drug development as one of its key priorities in 2013, Alfonso G...read more